Skip to main content
logo
The Hydration Pharmaceuticals Company Limited (ASX:HPC)
Australia flag Australia · Delayed Price · Currency is AUD
0.0020
-0.0010 (-33.33%)
Oct 23, 2026, 4:10 PM AEDT

ASX:HPC Ratios and Metrics

Millions AUD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
12561548
Market Cap Growth
-72.25%-60.75%-13.75%-56.82%-69.49%-
Enterprise Value
0-1119650
Last Close Price
0.000.010.020.020.090.29

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--1.27---
PS Ratio
0.520.581.061.011.105.73
PB Ratio
1.701.011.24-12.112.522.66
P/TBV Ratio
1.701.011.24-2.522.66

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
0.31-2.171.470.415.98

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
----10.870.93-
Net Debt / Equity Ratio
-0.67-0.79-1.17-5.73-0.24-0.81
Net Debt / EBITDA Ratio
----0.091.56
Net Debt / FCF Ratio
0.150.310.83-0.360.101.32
Asset Turnover
0.830.690.550.500.710.62
Inventory Turnover
1.391.130.910.831.701.97
Quick Ratio
0.901.551.601.152.245.68
Current Ratio
2.132.832.242.133.887.44
Return on Equity (ROE)
-147.39%-132.24%-476.06%-399.03%-123.28%-117.56%
Return on Assets (ROA)
-65.54%-54.70%-44.89%-50.24%-52.06%-43.25%
Return on Capital Employed (ROCE)
-413.10%-221.70%-151.90%-193.00%-138.70%-51.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-414.55%-199.12%78.54%-186.79%-105.89%-25.49%
FCF Yield
-262.07%-254.31%-114.21%-132.09%-97.35%-23.00%
Buyback Yield / Dilution
-6.18%-3.87%-91.04%-19.95%-115.37%-16.35%